K
Kyung Nam Pharm Co Ltd
KOSDAQ:053950
Kyung Nam Pharm Co Ltd
KOSDAQ:053950
Price:
642
KRW
-2.58%
Market Closed
Market Cap:
₩50.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
K
|
Kyung Nam Pharm Co Ltd
KOSDAQ:053950
|
KR |
|
M
|
MYND Life Sciences Inc
CNSX:MYND
|
CA |
|
Compania Minera Autlan SAB de CV
BMV:AUTLANB
|
MX |
|
Core Scientific Inc
NASDAQ:CORZ
|
US |
Relative Value
The Relative Value of one Kyung Nam Pharm Co Ltd stock under the Base Case scenario is hidden KRW. Compared to the current market price of 642 KRW, Kyung Nam Pharm Co Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Kyung Nam Pharm Co Ltd Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Kyung Nam Pharm Co Ltd Competitors
Kyung Nam Pharm Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
K
|
Kyung Nam Pharm Co Ltd
KOSDAQ:053950
|
50.2B KRW | 0.9 | -8.7 | 30.1 | -3.8 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
860.3B USD | 13.1 | 41.2 | 27.9 | 29.7 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.9B USD | 6 | 21 | 14.6 | 18 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.3B CHF | 3.9 | 18.8 | 11.2 | 12.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
213.1B GBP | 4.9 | 28 | 15.5 | 21.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
286.3B USD | 4.4 | 15.7 | 9.7 | 11.9 | |
| CH |
|
Novartis AG
SIX:NOVN
|
222.8B CHF | 5.1 | 20.7 | 12.8 | 16.5 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.4 | 10.3 | 7.6 | 8.9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
152.2B USD | 2.4 | 19.7 | 7.6 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
114.7B USD | 2.4 | 16.4 | 7 | 8.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
